Abound Wealth Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$379 Hold
2
﹤0.01% 992
2026
Q1
$187 Hold
2
﹤0.01% 1254
2025
Q4
$161 Hold
2
﹤0.01% 1264
2025
Q3
$196 Hold
2
﹤0.01% 1125
2025
Q2
$140 Hold
2
﹤0.01% 1159
2025
Q1
$100 Hold
2
﹤0.01% 1231
2024
Q4
$140 Sell
2
-1
-33% -$83 ﹤0.01% 1180
2024
Q3
$315 Hold
3
﹤0.01% 970
2024
Q2
$427 Hold
3
﹤0.01% 878
2024
Q1
$335 Sell
3
-2
-40% -$238 ﹤0.01% 1079
2023
Q4
$649 Buy
5
+3
+150% +$413 ﹤0.01% 861
2023
Q3
$327 Hold
2
﹤0.01% 983
2023
Q2
$367 Buy
+2
New +$288 ﹤0.01% 966

Other funds holding ACLS

Abound Wealth Management's ACLS Position: Q2 2026 in Review

Abound Wealth Management held its Axcelis (ACLS) position steady in Q2 2026 at 2 shares worth $379. The position accounts for ﹤0.01% of the portfolio, ranked #992.

Abound Wealth Management first reported a position in ACLS in Q2 2023 and has held it in 13 quarters since. The position peaked at $649 in Q4 2023. 40 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Abound Wealth Management held 2 shares of Axcelis worth $379 as of Q2 2026.
  • Abound Wealth Management left its Axcelis share count unchanged in Q2 2026.
  • Axcelis made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #992 holding.
  • Abound Wealth Management first reported a position in Axcelis in Q2 2023 and has held it in 13 quarters since.
  • Abound Wealth Management's Axcelis position peaked at $649 in Q4 2023.
  • 40 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.